INNV-14. ADJUVANT CHEMOTHERAPY AFTER SEVERE MYELOTOXICITY DURING TEMOZOLOMIDE CHEMORADIATION IN GLIOMAS. IT IS FEASIBILE?

INTRODUCTION: Malignant gliomas are aggressive primitive brain tumor in adults. Today, the standard of care is Temozolomide (TMZ) administered daily with radiation therapy, followed by adjuvant TMZ. TMZ treatment has been considered to have a low toxicity profile. However, during concomitant treatme...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Villani, Veronica, Fabi, Alessandra, Gaviani, Paola, Rudà, Roberta, Lombardi, Giuseppe, Simonetti, Giorgia, Silvani, Antonio, Pronello, Edoardo, Minniti, Giuseppe, Pace, Andrea
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Innovations in Patient Care
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847069/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.557
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak